Table 2.
Pathway enrichment analysis for the 387 replicated metabolites associated with total fat (%).
| Metabolite set | Hits | Expected | Total | P-value |
|---|---|---|---|---|
| Aminoacyl-tRNA biosynthesis | 15 | 2.91 | 48 | 3.84E−08 |
| Valine, leucine and isoleucine biosynthesis | 6 | 0.49 | 8 | 1.08E−06 |
| Arginine biosynthesis | 7 | 0.85 | 14 | 5.86E−06 |
| Glycine, serine and threonine metabolism | 10 | 2.00 | 33 | 1.21E−05 |
| Alanine, aspartate and glutamate metabolism | 9 | 1.70 | 28 | 2.01E−05 |
| Cysteine and methionine metabolism | 9 | 2.0013 | 33 | 8.69E−05 |
| Pantothenate and CoA biosynthesis | 6 | 1.15 | 19 | 6.05E−04 |
| Phenylalanine, tyrosine and tryptophan biosynthesis | 3 | 0.24 | 4 | 8.27E−04 |
| Glycerophospholipid metabolism | 8 | 2.18 | 36 | 1.00E−03 |
| Sphingolipid metabolism | 6 | 1.27 | 21 | 1.10E−03 |
| D-Glutamine and D-glutamate metabolism | 3 | 0.36 | 6 | 3.78E−03 |
| Taurine and hypotaurine metabolism | 3 | 0.49 | 8 | 9.68E−03 |
| Nicotinate and nicotinamide metabolism | 4 | 0.91 | 15 | 1.03E−02 |
| Glyoxylate and dicarboxylate metabolism | 6 | 1.94 | 32 | 1.06E−02 |
| Histidine metabolism | 4 | 0.97 | 16 | 1.31E−02 |
| Phenylalanine metabolism | 3 | 0.61 | 10 | 1.90E−02 |
| Nitrogen metabolism | 2 | 0.36 | 6 | 4.65E−02 |
Total, total number of metabolites in this metabolite set (pathway); expected, expected number of metabolites projected to each set; hits, observed number of metabolites of interest projected to each set.